Drug intelligence / Profile preview

Osteo-Form

Development stage: Unknown
Lead developer: Lloyd Healthcare
Modality: Small Molecules
Administration: Oral

Overview

Osteo-Form is a veterinary nutritional supplement developed and manufactured by LLOYD, Inc. (Lloyd Pharma). It is formulated as a powder or chewable tablet containing a balanced ratio of calcium and phosphorus, along with vitamins A, D3, and C. The product is primarily indicated for the correction of dietary deficiencies and as an aid in the treatment of metabolic bone diseases, such as rickets or osteomalacia, in dogs, cats, and horses. By providing essential minerals and vitamins, Osteo-Form supports bone mineralization, structural integrity, and collagen matrix synthesis, particularly in pregnant, lactating, or rapidly growing animals.

Brand names: Osteo-FormOsteo-Form Powder

Targets

VDR (Vitamin D receptor)RAR (Retinoic acid receptor)

Beyond the preview

Go deeper on Osteo-Form.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Osteo-Form.

Explore the full profile